Mary Elizabeth Strek to Dose-Response Relationship, Drug
This is a "connection" page, showing publications Mary Elizabeth Strek has written about Dose-Response Relationship, Drug.
Connection Strength
0.127
-
COVIDOSE: A Phase II Clinical Trial of Low-Dose Tocilizumab in the Treatment of Noncritical COVID-19 Pneumonia. Clin Pharmacol Ther. 2021 03; 109(3):688-696.
Score: 0.036
-
Myositis-associated Interstitial Lung Disease: Predictors of Failure of Conventional Treatment and Response to Tacrolimus in a US Cohort. J Rheumatol. 2017 Nov; 44(11):1612-1618.
Score: 0.028
-
Physiologic significance of epithelial removal on guinea pig tracheal smooth muscle response to acetylcholine and serotonin. Am Rev Respir Dis. 1993 Jun; 147(6 Pt 1):1477-82.
Score: 0.021
-
Direct effects and augmentation of airway smooth muscle contraction caused by phospholipase A2. Am Rev Respir Dis. 1992 Jun; 145(6):1463-8.
Score: 0.020
-
Cilomilast for COPD: results of a 6-month, placebo-controlled study of a potent, selective inhibitor of phosphodiesterase 4. Chest. 2006 Jan; 129(1):56-66.
Score: 0.013
-
Regulation of human eosinophil degranulation and activation by endogenous phospholipase A2. J Clin Invest. 1993 May; 91(5):2118-25.
Score: 0.005
-
Effects of PAF on isolated rat airways perfused with blood-free solution. Am J Physiol. 1991 Apr; 260(4 Pt 1):L260-7.
Score: 0.005